This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Newbold, R. R. Articles by Jefferson, W. N. Search for Related Content PubMed PubMed Citation Articles by Newbold, R. R. Articles by Jefferson, W. N.

Adverse Effects of the Model Environmental Estrogen Diethylstilbestrol Are Transmitted to Subsequent Generations

Developmental Endocrinology and Endocrine Disruptor Section, Laboratory of Molecular Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina 27709

Address all correspondence and requests for reprints to: Retha R. Newbold, Head Developmental Endocrinology Section, Mail-Drop E4-02, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709. E-mail: newbold1{at}niehs.nih.gov.

Abstract

The synthetic estrogen diethylstilbestrol (DES) is a potent perinatal endocrine disruptor. In humans and experimental animals, exposure to DES during critical periods of reproductive tract differentiation permanently alters estrogen target tissues and results in long-term abnormalities such as uterine neoplasia that are not manifested until later in life. Using the developmentally exposed DES mouse, multiple mechanisms have been identified that play a role in its carcinogenic and toxic effects. Analysis of the DES murine uterus reveals altered gene expression pathways that include an estrogen-regulated component. Thus, perinatal DES exposure, especially at low doses, offers the opportunity to study effects caused by weaker environmental estrogens and provides an example of the emerging scientific field termed the developmental origin of adult disease. As a model endocrine disruptor, it is of particular interest that even low doses of DES increase uterine tumor incidence. Additional studies have verified that DES is not unique; when other environmental estrogens are tested at equal estrogenic doses, developmental exposure results in increased incidence of uterine neoplasia similar to that caused by DES. Interestingly, our data suggest that this increased susceptibility for tumors is passed on from the maternal lineage to subsequent generations of male and female descendants; the mechanisms involved in these transgenerational events include genetic and epigenetic events. Together, our data point out the unique sensitivity of the developing organism to endocrine-disrupting chemicals, the occurrence of long-term effects after developmental exposure, and the possibility for adverse effects to be transmitted to subsequent generations.

This article has been cited by other articles:

				K. C. Grim, M. J. Wolfe, M. Edwards, J. Kaufman, S. Onjukka, P. Moran, and J. C. Wolf Epizootic Ameloblastomas in Chinook Salmon (Oncorhynchus tshawytscha) of the Northwestern United States Vet. Pathol., July 1, 2009; 46(4): 622 - 635. [Abstract] [Full Text] [PDF]

				D. C. Dolinoy, D. Huang, and R. L. Jirtle Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development PNAS, August 7, 2007; 104(32): 13056 - 13061. [Abstract] [Full Text] [PDF]